共 289 条
[1]
Edvinsson L(2008)CGRP blockers in migraine therapy: where do they act? Br J Pharmacol 155 967-969
[2]
Tfelthansen P(2012)Clinical pharmacology of current and future drugs for the acute treatment of migraine: a review and an update Curr Clin Pharmacol 7 66-72
[3]
David Dodick MD(2004)Consensus statement: cardiovascular safety profile of triptans (5-HT 1B/1D agonists) in the acute treatment of migraine Headache 44 414-425
[4]
Lipton RB(1994)5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives Naunyn Schmiedeberg’s Arch Pharmacol 350 225-229
[5]
Vincent Martin MD(2005)Serotonin (5‐HT) and Migraine Headache 34 408-417
[6]
Vasilios Papademetriou MD(2006)Calcitonin Gene-Related Peptide (CGRP) and Migraine Headache 46 S3-S8
[7]
Rosamond W(2002)CGRP may play a causative role in migraine Cephalalgia 22 54-61
[8]
Maassenvandenbrink A(2009)The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs Pharmacol Ther 124 309-323
[9]
Hassan Loutfi MD(2007)Dopamine and migraine: biology and clinical implications Cephalalgia 27 1308-1314
[10]
Welch KM(2007)A dopamine D4 receptor exon 3 VNTR allele protecting against migraine without aura Ann Neurol 61 574-578